These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15757296)

  • 1. [Therapeutic possibilities and clinical effects of IgE level modulation in allergic diseases].
    Bobrowska M; Stelmach I
    Pneumonol Alergol Pol; 2004; 72(1-2):70-4. PubMed ID: 15757296
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
    Belloni B; Ziai M; Lim A; Lemercier B; Sbornik M; Weidinger S; Andres C; Schnopp C; Ring J; Hein R; Ollert M; Mempel M
    J Allergy Clin Immunol; 2007 Nov; 120(5):1223-5. PubMed ID: 17936892
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model.
    Mo JH; Kang EK; Quan SH; Rhee CS; Lee CH; Kim DY
    Allergy; 2011 Feb; 66(2):279-86. PubMed ID: 21208219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE and immunoglobulin free light chains in allergic disease: new therapeutic opportunities.
    Redegeld FA; Wortel CH
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1185-91. PubMed ID: 18951298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution in immunological methods used in research and in the clinical diagnosis and management of human allergic diseases.
    Hamilton RG
    J Immunol Methods; 2012 Sep; 383(1-2):1-3. PubMed ID: 22750249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the study of allergic disease drugs targeting on IgE/FcepsilonRI signaling pathway].
    Liu ZC; Shi HL; Zhang YF; Zhao LJ
    Yao Xue Xue Bao; 2011 Oct; 46(10):1161-6. PubMed ID: 22242444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-IgE--a new treatment for allergic diseases].
    Berkun Y; Shalit M
    Harefuah; 2002 Mar; 141(3):260-2, 314. PubMed ID: 11944220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
    Kupryś-Lipińska I; Kuna P
    Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface plasmon resonance analysis of free IgE in allergic patients receiving omalizumab (Xolair).
    Hamilton RG; Saini SS; MacGlashan D
    J Immunol Methods; 2012 Sep; 383(1-2):54-9. PubMed ID: 22658968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On asthma and allergic reactions. Omalizumab: from IgE to anti-IgE].
    Ladetzki-Baehs K; Dirsch VM; Vollmar AM
    Pharm Unserer Zeit; 2004; 33(2):116-22. PubMed ID: 15083621
    [No Abstract]   [Full Text] [Related]  

  • 13. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab, a monoclonal antibody against IgE for the treatment of allergic diseases.
    Solèr M
    Int J Clin Pract; 2001 Sep; 55(7):480-3. PubMed ID: 11594260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of omalizumab in the treatment of nasal polyps.
    Vennera Mdel C; Picado C; Mullol J; Alobid I; Bernal-Sprekelsen M
    Thorax; 2011 Sep; 66(9):824-5. PubMed ID: 21109700
    [No Abstract]   [Full Text] [Related]  

  • 17. [Allergic disease treatments: classic and innovative therapeutics].
    Têtu L; Didier A
    Rev Prat; 2007 Jun; 57(12):1339-48. PubMed ID: 17717947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study.
    Dal Negro RW; Guerriero M; Micheletto C; Tognella S; Visconti M
    J Asthma; 2011 Jun; 48(5):437-41. PubMed ID: 21599560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the IgE molecule in allergic and asthmatic diseases: review of the IgE molecule and clinical efficacy.
    Poole JA; Matangkasombut P; Rosenwasser LJ
    J Allergy Clin Immunol; 2005 Mar; 115(3):S376-85. PubMed ID: 15753882
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting IgE in allergic disease.
    Gasser P; Eggel A
    Curr Opin Immunol; 2018 Oct; 54():86-92. PubMed ID: 29986302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.